The letter

One letter a week, starting soon.

The week's signal, what shipped, what is worth running tonight, and the editor's note. No tracking, no ads, nothing else.

We keep your address, your language and the date you joined, nothing else. Every letter has a one-click unsubscribe link that deletes the record.

← Accept All   Archive
Tech.euEurope

Biomatter lands $18M to speed up enzyme development with AI

11.12

Biomatter , a company specialising in custom enzyme design, has raised $18 million in an oversubscribed Series A funding round led by Astanor , with participation from existing investors UVC Partners…

Funding & deals
Read at Tech.eu ↗

Related

More from Tech.eu on Accept All.